CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 8-K Event Executive or director change · Other events
- 4 Open-market sale Pres. Diagnostics & Genom sold 500 shares at an average $505.38 ($252,689)
- 4 Open-market sale President-Protein Sciences sold 27,159 shares at an average $504.00 ($13,688,193)
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Financial Officer sold 9,022 shares at an average $526.49 ($4,749,990)
- 8-K Event Results of operations · Other events
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 762 shares at an average $525.23 ($400,222)
- 4 Grant or award Director acquired 194 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Open-market sale Pres. Diagnostics & Genom sold 822 shares at $529.04 ($434,871)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
Page 16 of 65 · 1,282 filings